Aprotinin reduces the need for blood products during liver transplantation
- 1 May 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 169 (5) , 546-549
- https://doi.org/10.1016/s0002-9610(99)80215-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Definition and Classification of Negative Outcomes in Solid Organ Transplantation Application in Liver TransplantationAnnals of Surgery, 1994
- Coagulation changes and the influence of the early perfusate in the course of orthotopic liver transplantation (OLT) when aprotinin is used intra-operativelyBlood Coagulation & Fibrinolysis, 1991
- Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantationThe Lancet, 1990
- The serine antiprotease aprotinin (Trasyloltm)Blood Coagulation & Fibrinolysis, 1990
- SYSTEMIC EFFECTS OF TISSUE PLASMINOGEN ACTIVATOR-ASSOCIATED FIBRINOLYSIS AND ITS RELATION TO THROMBIN GENERATION IN ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1989
- Liver transplantation: An overviewHepatology, 1988
- Fibrinolysis during liver transplantation in humans: role of tissue- type plasminogen activatorBlood, 1988
- Influence of Selected Patient Variables and Operative Blood Loss on Six-Month Survival Following Liver TransplantationSeminars in Liver Disease, 1985
- Refinements in the Surgical Technique of Liver TransplantationSeminars in Liver Disease, 1985
- Blood transfusion in liver transplantationTransfusion, 1985